Jonas Montana is the founder of Calluna Pharma. Calluna Pharma has raised $81M in total funding. Latest round: Series A. Backed by Forbion, Sarsia, p53.
John Montana is the Chief Executive Officer of Calluna Pharma, a company formed from the merger of Oxitope Pharma and Arxx Therapeutics. Calluna Pharma focuses on developing novel therapies for inflammatory and fibrotic diseases, leveraging the innate immune system. The company aims to address unmet clinical needs with therapies that offer superior efficacy and improved patient tolerance.
Full founder directory · Investor directory · Company funding database · Fundraising library